PF-05241328 | Interleukin Related interleukin-related.com

Product Name :
PF-05241328

Search keywords :
PF-05241328

drugId :
null

Target Vo:
Sodium channel protein type IX alpha subunit

Target Vo Short Name :
SCN9A

Moa_Name:
Sodium channel protein type IX alpha subunit blockers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD41 Rabbit mAb Purity & Documentation
Enfortumab Cancer
GPR30 Antibody: GPR30 Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-GPR30 polyclonal antibody. GPR30 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: chicken, cow, horse, rabbit background without labeling.

Author: Interleukin Related

Related Posts